Systems and methods for the treatment of pain through neural fiber stimulation of efferent nerve fiber

• US 9,616,229 B2
• Filed: 07/21/2014
• Issued: 04/11/2017
• Est. Priority Date: 11/11/2010
• Status: Active Grant

• Current Assignee: SPR Therapeutics, Inc.
• Original Assignee: SPR Therapeutics, LLC (SPR Therapeutics, Inc.)
• Inventors: Boggs, II, Joseph W., Bennett, Maria E., Grill, Warren M., Chae, John
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): Carey, Michael
• Application Number:
  US14/336,633
• Publication Number:
  US 20140330340A1
• Time in Patent Office: 995 Days
• Field of Search: 607 46, 607 48, 607115
• CPC Class Codes: A61N 1/36003 of motor muscles, e.g. for walking assistance
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36021 for treatment of pain
• CPC Class Codes: A61N 1/36057 adapted for stimulating afferent nerves
• CPC Class Codes: A61N 1/36071 Pain

Abstract

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

Claims

1. A method of reducing a perception of pain, the method comprising the steps of:

inserting a single contact electrode in-vivo a therapeutically effective distance from a target efferent nerve fiber;

electrically stimulating through the electrode the target efferent nerve fiber to generate an action potential in the target efferent nerve fiber while avoiding generation of action potentials in a non-target nerve fiber.

2. The method of claim 1, wherein the therapeutically effective distance is greater that 1 mm from the target afferent nerve fiber.

3. The method of claim 1, wherein the target efferent nerve fiber is located between a neurological motor point and the central nervous system of a human.

4. The method of claim 1, wherein the generation of action potentials in a non-target nerve fiber includes avoiding generation of action potentials in a small sensory nerve fiber.

5. The method of claim 1, wherein the generation of action potentials in the non-target nerve fiber comprises generation of action potentials in Type III and Type IV nerve fibers.

6. The method of claim 1, wherein the target efferent nerve fibers comprise motor axons.

7. The method of claim 6, wherein the motor axons comprise Aα

axons.

8. The method of claim 1, further comprising percutaneously inserting a lead, the lead operatively coupled with the electrode.

9. The method of claim 1, wherein the target efferent nerve fiber is located within a region of pain.

10. The method of claim 1, wherein the target efferent nerve fiber is located outside of a region of pain.

11. A method of reducing a perception of pain, the method comprising the steps of:

percutaneously inserting a lead, the lead having an electrode, wherein the electrode is at a therapeutically effective distance from a target efferent nerve fiber;

electrically stimulating through the electrode the target efferent nerve fiber to generate an action potential in the target efferent nerve fiber while avoiding generation of action potentials in a non-target nerve fiber; and

removing the lead and electrode, wherein pain relief is generally maintained for a time after the removal.

12. The method of claim 11, wherein the electrode is a single contact electrode.

13. The method of claim 11, wherein the non-target nerve fiber includes Type III and Type IV afferent nerve fibers.

14. The method of claim 11, wherein the electrical stimulation relieves pain.

15. The method of claim 11, wherein the time is at least two weeks.

16. The method of claim 11, wherein the target efferent nerve fiber comprises a motor axon.

17. The method of claim 16, wherein the motor axon comprises an Aα

axon.

18. The method of claim 16, wherein the motor axon comprises an Aγ

axon.

19. The method of claim 16, wherein the non-target nerve fiber includes at least one small sensory nerve fiber.

20. The method of claim 19, wherein the time is at least two weeks.

21. The method of claim 15, wherein the non-target nerve fiber includes a motor sensory nerve fiber.

22. A method of reducing a perception of pain, the method comprising:

electrically stimulating through a single contact electrode inserted in-vivo a plurality of target efferent motor nerve fibers to generate an action potential in the plurality of target efferent motor nerve fibers while avoiding generation of action potentials in small sensory nerve fibers.

23. The method of claim 22, wherein the small sensory nerve fibers include Type III and IV nerve fibers.

24. The method of claim 22, further comprising percutaneously inserting a lead having an electrode.

25. The method of claim 24, wherein the electrode is inserted a therapeutically effective distance from the target efferent motor nerve fibers.

26. The method of claim 25, wherein the therapeutically effective distance is no less than 1 mm from the target efferent motor nerve fibers.

27. The method of claim 22, wherein the electrical stimulation is applied for a treatment time to relieve pain.

28. The method of claim 27, wherein after the treatment time pain relief is maintained for a period of time, such period of time at least 17 times the treatment time.

29. The method of claim 22, wherein generating the action potential in the plurality of target efferent motor nerve fibers causes a contraction of muscle.